ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Andrew M. EvensPhillip ScheinbergThe British Journal of Haematology announced the appointment of Andrew M. Evens as its editor-in-chief, effective Jan. 1, 2025.

December 06, 2024

Vol.50 No.45

In Brief

Siemens Healthineers, Ohio State Wexner Medical Center form 10-year, $105M partnership

Siemens Healthineers and The Ohio State Wexner Medical Center have expanded their existing strategic relationship to form a 10-year, $105 million value partnership to foster breakthroughs in clinical care, in addition to their longstanding research collaboration.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Cedars-Sinai to develop AI tool that predicts pancreatic cancer risk in Black patients

Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the disease.

December 06, 2024

Vol.50 No.45

In Brief

Argonne National Laboratory receives $22M from ARPA-H to accelerate cancer therapy, vaccine discoveries using AI

The U.S. Department of Energy’s Argonne National Laboratory will use its world-leading capabilities in artificial intelligence and high-performance computing to research novel ways to fight cancer and advance vaccine discovery.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints

Merck announced positive topline results from the pivotal phase III MK-3475A-D77 trial.

November 22, 2024

Vol.50 No.44

Clinical Roundup

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Researchers at City of Hope found that taking white button mushroom pills reduces a class of immune cells called myeloid-derived suppressor cells, which has been linked to cancer development and spread.

November 22, 2024

Vol.50 No.44

ConcertAI and NeoGenomics announce AI software-as-a-service solution for hematology clinical research

YOU MAY BE INTERESTED IN

Andrew Evens named editor-in-chief of the British Journal of Haematology; Phillip Scheinberg named editor-in-chief of eJHaem

Siemens Healthineers, Ohio State Wexner Medical Center form 10-year, $105M partnership

Cedars-Sinai to develop AI tool that predicts pancreatic cancer risk in Black patients

Argonne National Laboratory receives $22M from ARPA-H to accelerate cancer therapy, vaccine discoveries using AI

Phase III trial of subcutaneous pembrolizumab with berahyaluronidase alfa meets primary endpoints

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

Renew today!

Subscriber content

Never miss an issue!

Login